Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDB1- and CUL4-associated factor 1 (DCAF1) is a substrate receptor protein within the CUL4-DDB1 E3 ubiquitin ligase complex. This protein is characterized by the presence of WD40 repeat domains and a chromo domain that enable it to recognize and bind methylated proteins, leading to their ubiquitination and subsequent degradation via the proteasome[3][4]. DCAF1 plays pivotal roles in regulating the cell cycle, chromatin remodeling, and protein turnover, making it essential for processes such as embryogenesis, gametogenesis, and maintenance of genome stability[1][2][3][4]. Aberrant function or regulation of DCAF1 has been implicated in cancer, viral infection (notably through interaction with HIV-1 Vpr), and genetic syndromes such as Woodhouse-Sakati syndrome (via DCAF17 mutation), which causes developmental, neurological, and reproductive disorders[2][4]. Given its central role in protein homeostasis and cell cycle regulation, DCAF1 is an emerging target in therapeutics research, especially in oncology and infectious disease[4].
Targeted protein degradation; Modulation of cell cycle checkpoints
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDB1- and CUL4-associated factor 1 (DCAF1).